Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-033919
Filing Date
2024-11-07
Accepted
2024-11-07 16:13:00
Documents
94
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20240930_10q.htm   iXBRL 10-Q 2562460
2 EXHIBIT 31.1 ex_738507.htm EX-31.1 7889
3 EXHIBIT 31.2 ex_738515.htm EX-31.2 8222
4 EXHIBIT 32.1 ex_738517.htm EX-32.1 3917
5 EXHIBIT 32.2 ex_738518.htm EX-32.2 3895
  Complete submission text file 0001437749-24-033919.txt   13673763

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nby-20240930.xsd EX-101.SCH 112710
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20240930_def.xml EX-101.DEF 766225
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20240930_lab.xml EX-101.LAB 568252
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20240930_pre.xml EX-101.PRE 804836
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20240930_cal.xml EX-101.CAL 45102
97 EXTRACTED XBRL INSTANCE DOCUMENT nby20240930_10q_htm.xml XML 2832369
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 241435845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)